Influenza A virus vaccine H9N2 (Baxalta)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInfluenza A virus vaccine H9N2 (Baxalta)
Drug Alias NameReverse genetic reassortant H9N2 influenza vaccine甲型流感病毒疫苗株 - Baxalta
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsInfluenza A virus infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesBaxalta Incorporated
China Registration ClassN/A

Develop Information

Active CompaniesBaxalta Incorporated
Inactive CompaniesN/A
Active IndicationsInfluenza A virus infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A